Our References

Discover everything you need to know about Irritable Bowel Syndrome (IBS) and the limitations of its current treatments through our reference list.

Global Prevalence of IBS

Around 10-15% of the global population is estimated to suffer from IBS.

Symptons Severity Impact

Approximately 30% of individuals with IBS have severe symptoms.

Gender Differences

Women are twice as likely to be affected by IBS compared to men.

Source: Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis

Economic Burden

IBS results in a significant economic burden due to healthcare costs and lost productivity.

Impact on Quality of Life

IBS negatively affects the quality of life for approximately 40% of sufferers.

Psychological Impact

About 50-90% of individuals with IBS also experience anxiety or depression.

Impact on Global Healthcare

IBS contributes to millions of visits to healthcare providers annually worldwide.

IBS in Australia

Approximately 1 in 7 Australians are affected by IBS.

Economic Impact on the Australian Healthcare System

IBS costs the Australian healthcare system approximately $1.5 billion annually.

Dissatisfaction with Over the Counter Treatments

Less than 20% of patients with IBS were satisfied with over the counter treatments.

Dissatisfaction with Prescription Treatments

63% were not satisfied with prescription treatment.

Evidence-based treatments for
gastrointestinal diseases
Want to stay up to date with our trials and latest news?
Sign up here

    All rights reserved © Anatara Lifesciences 2023